BioLineRx Ltd. To Report First Quarter 2014 Results On May 20, 2014
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it will release its unaudited financial results for the quarter ended March 31, 2014 on Tuesday, May 20, 2014, before the U.S. markets open.
Help employers find you! Check out all the jobs and post your resume.